Swallow the tablet whole with a small amount of water (no more than 120mL)
Current trials also exclude people with diabetes, recent heart problems, and eating disorders, which may indicate future contraindications once approved
This gradual dose escalation helps minimize gastrointestinal adverse effects
First, it provides a comprehensive investigation of the associations between GLP-1RAs and 12 common psychiatric and neurodevelopmental conditions, utilizing large-scale GWAS summary statistics
At baseline, 2735 of the patients (83.0%) had established cardiovascular disease, chronic kidney disease, or both
2e) and immunofluorescence microscopy (Fig